LCD-L34213
Document details
Summary
The updated Local Coverage Determination (LCD) for Diagnostic and Therapeutic Colonoscopy by Noridian may impact billing by establishing new guidelines that dictate coverage and reimbursement. This coNew guidelines for colonoscopy billing effective Nov 2025.
Affected codes
ICD-10-CM
Affected specialty
Gastroenterology alerts →Source document
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=34213&ver=56CLV Intelligence summarizes publicly available federal publications. Not affiliated with or endorsed by any government agency.
Related alerts
4Policy FDA-NDA022231 · Gastroenterology
Terlivaz (terlipressin) is an injectable medication, likely to receive an assigned J-code for billing under Medicare Part B. Given its status as an orphan drug, it may qualify for pass-through payment
View alertPolicy LCD-DL38571 · Gastroenterology
The proposed LCD for Colon Capsule Endoscopy (CCE) may lead to increased compliance updates for gastroenterology practices, as it could allow for reimbursement for procedures that were previously n
View alertPolicy LCD-DL40187 · Gastroenterology
The proposed LCD for biomarker testing aims to clarify coverage criteria for metabolic dysfunction-associated conditions, potentially increasing access for necessary testing. This may lead to improved
View alertPolicy LCD-DL40272 · Gastroenterology
The proposed LCD for biomarker testing in metabolic liver disease may affect reimbursement practices by clarifying coverage policies which could lead to increased utilization of these tests. Providers
View alert